hit counter
Cellular Biomedicine Group, Inc. (CBMG) Stock News Sentiment & Price - Sentifly
CBMG - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Cellular Biomedicine Group, Inc. (CBMG)

USA
Biotechnology
NASDAQ
CBMG Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CBMG Latest news
PRNewsWire
Neutral
Cellular Biomedicine Group, Inc. Announces Completion of Merger
2021-02-19 14:55

ROCKVILLE, Md. and SHANGHAI, Feb. 19, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") today announced the completion of the merger (the "Merger") of the Company with CBMG Merger Sub Inc., a Delaware corporation ("Merger Sub") and a...

PRNewsWire
Neutral
Cellular Biomedicine Group, Inc. Stockholders Approve Merger
2021-02-08 16:19

ROCKVILLE, Md. and SHANGHAI, Feb. 8, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") announced that, at the Company's special meeting of stockholders held today, its stockholders approved the proposal to adopt the previously announced...

PRNewsWire
Neutral
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
2021-01-28 16:30

ROCKVILLE, Md. and SHANGHAI, Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company," "CBMG," "we" or "our"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases,...

PRNewsWire
Neutral
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CIT, HMSY, INFO, PS, SPWH, UROV, and WDR
2021-01-24 11:10

NEW YORK, Jan. 24, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like...

PRNewsWire
Neutral
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, CLCT, EIGI, FBM, HDS, IPHI and PNM
2020-12-17 23:22

NEW YORK, Dec. 17, 2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like...

PRNewsWire
Neutral
Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting
2020-12-04 07:35

GAITHERSBURG, Md. and SHANGHAI, Dec. 4, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today...

PRNewsWire
Neutral
Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights
2020-11-09 17:24

GAITHERSBURG, Md. and SHANGHAI, Nov. 9, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today reported...

Seeking Alpha
Positive
Cellular Biomedicine Group, Inc.: 10% Return In A Few Months As Merger Should Receive Approval
2020-11-02 14:26

CBMG agreed to be taken private at $19.75 per share in cash. The transaction is subject to shareholder approval as well as CFIUS clearance.

PRNewsWire
Neutral
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - CBMG, VRTU, MR, IMMU, JCAP
2020-10-05 23:02

NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a...

Business Wire
Neutral
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – RST, CBMG, AIMT, AKCA
2020-09-12 09:36

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating: Rosetta Stone Inc. (NYSE: RST) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Cambium Learning Group for $30 per share.

Loading more news...